[Current status of cancer management. 3. New molecular targets in cancer chemotherapy].
Nakano
S
S
D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis; D004351:Drug Resistance; D066246:ErbB Receptors; D006801:Humans; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy*; D009389:Neovascularization, Pathologic; D018719:Erb-b2 Receptor Tyrosine Kinases; D015398:Signal Transduction / Q000187:drug effects
D000970:Antineoplastic Agents; D066246:ErbB Receptors; D018719:Erb-b2 Receptor Tyrosine Kinases